SLC9A3 and inflammatory bowel disease: In turn, the pathological state of IBD can further reshape the gut microbiota by influencing expansion of certain pathobionts that consequently inhibit NHE3 activity (Hayashi et al., 2004; Subramanya et al., 2007; Hodges et al., 2008), which reciprocally aggravates dysbiosis and IBD.